Rebranding underscores Henry Schein's leadership in the global animal health market
MELVILLE, N.Y., March 19, 2013 /PRNewswire/ -- Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners, today announced that Butler Schein Animal Health, the leading distributor in the U.S. companion animal health market, will be rebranded as Henry Schein Animal Health. The rebranding plan was announced at the Butler Schein Animal Health national sales meeting inOrlando, Fla., and the rebranding process will take place throughout 2013.
"This transition from Butler Schein Animal Health to Henry Schein Animal Health underscores our increasing strength in the global animal health market and our commitment to be a valuable resource to our customers and supplier partners around the world," said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer for Henry Schein. "We now serve 68,000 veterinary customers across 14 countries, delivering tailored solutions that combine our global resources with local market knowledge. This rebranding preserves the rich heritage of Butler Schein and links our United States operations more closely with our market-leading animal health businesses throughout Europe and Australasia."
Butler Schein Animal Health was created in 2010 through the merger of Butler Animal Health Supply (which included The Butler Company and Burns Veterinary Supply) and Henry Schein Animal Health (which included NLS Animal Health), and immediately became the leading U.S. companion animal health distributor. It represents the largest component of Henry Schein's global animal health business. Henry Schein also is the leading animal health provider in Australia, New Zealand,The Netherlands, Belgium, Germany, Switzerland, Ireland and the Czech Republic, with operations in Spain, Portugal, the U.K., France and Austria, as well. In addition, Henry Schein is a leading global provider of animal health practice management software solutions.
"As Henry Schein continues to grow our leadership in the global animal health market, it is important that the Henry Schein Animal Health brand is prominent in the world's largest veterinary market – the United States," said Lonnie Shoff, President and CEO, Henry Schein Global Animal Health and Strategic Partnerships. "We are now the leading provider of animal health solutions on three continents. As our brands become increasingly aligned from country to country, we reinforce the strength of the best practices that we share among our operating units around the world."
"This rebranding is another step in the continuing growth and evolution of our company," said Kevin R. Vasquez, Chairman, CEO and President of Butler Schein. "By more closely aligning our organization with the Henry Schein global brand, we are demonstrating that we have the long-term strength of a diversified global partner – a company that truly thinks globally and acts locally to serve our customers. We look forward to continuing to build on our record of success as Henry Schein Animal Health." About Henry Schein, Inc.
Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners. The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. A Fortune 500® Company and a member of the NASDAQ 100® Index, Henry Schein employs more than 15,000 Team Schein Members and serves more than 775,000 customers.
The Company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 96,000 branded products and Henry Schein private-brand products in stock, as well as more than 110,000 additional products available as special-order items. The Company also offers its customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services.
Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 25 countries. The Company's sales reached a record $8.9 billion in 2012, and have grown at a compound annual rate of 17 percent since Henry Schein became a public company in 1995. For more information, visit the Henry Schein Web site at www.henryschein.com
. Cautionary Note Regarding Forward-Looking Statements
In accordance with the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995, we provide the following cautionary remarks regarding important factors that, among others, could cause future results to differ materially from the forward-looking statements, expectations and assumptions expressed or implied herein. All forward-looking statements made by us are subject to risks and uncertainties and are not guarantees of future performance. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance and achievements or industry results to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.
These statements are identified by the use of such terms as "may," "could," "expect," "intend," "believe," "plan," "estimate," "forecast," "project," "anticipate" or other comparable terms. A full discussion of our operations and financial condition, including factors that may affect our business and future prospects, is contained in documents we have filed with the SEC and will be contained in all subsequent periodic filings we make with the SEC. These documents identify in detail important risk factors that could cause our actual performance to differ materially from current expectations.
Risk factors and uncertainties that could cause actual results to differ materially from current and historical results include, but are not limited to: effects of a highly competitive market; our dependence on third parties for the manufacture and supply of our products; our dependence upon sales personnel, customers, suppliers and manufacturers; our dependence on our senior management; fluctuations in quarterly earnings; risks from expansion of customer purchasing power and multi-tiered costing structures; possible increases in the cost of shipping our products or other service issues with our third-party shippers; general global macro-economic conditions; disruptions in financial markets; possible volatility of the market price of our common stock; changes in the health care industry; implementation of health care laws; failure to comply with regulatory requirements and data privacy laws; risks associated with our global operations; transitional challenges associated with acquisitions and joint ventures, including the failure to achieve anticipated synergies; financial risks associated with acquisitions and joint ventures; litigation risks; the dependence on our continued product development, technical support and successful marketing in the technology segment; risks from rapid technological change; risks from disruption to our information systems; certain provisions in our governing documents that may discourage third-party acquisitions of us; and changes in tax legislation. The order in which these factors appear should not be construed to indicate their relative importance or priority.
We caution that these factors may not be exhaustive and that many of these factors are beyond our ability to control or predict. Accordingly, any forward-looking statements contained herein should not be relied upon as a prediction of actual results. We undertake no duty and have no obligation to update forward-looking statements.